Whitehawk Therapeutics Inc
(WHWK)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -110,090 | -94,100 | -7,012 | -5,476 | -3,478 |
| Depreciation Amortization | 74,261 | 74,189 | 4 | 2 | 9 |
| Accounts receivable | 14,149 | 14,149 | 14,149 | 14,029 | -13,864 |
| Accounts payable and accrued liabilities | 8,290 | N/A | N/A | N/A | 1,079 |
| Other Working Capital | 12,245 | 10,257 | 15,173 | 14,568 | -10,506 |
| Other Operating Activity | -21,278 | -14,490 | -14,936 | -12,560 | 14,059 |
| Operating Cash Flow | $-22,423 | $-9,995 | $7,378 | $10,563 | $-12,701 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -46 | N/A | N/A | N/A | N/A |
| Net Acquisitions | 29,700 | 29,700 | -157 | N/A | N/A |
| Other Investing Activity | -4,501 | -4,501 | 0 | 0 | 0 |
| Investing Cash Flow | $25,153 | $25,199 | $-157 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 1,194 |
| Common Stock Issued | 155,833 | 155,745 | N/A | N/A | N/A |
| Dividend Paid | -4,412 | -4,412 | N/A | N/A | N/A |
| Other Financing Activity | -9,617 | -9,617 | -1 | 0 | 0 |
| Financing Cash Flow | $141,804 | $141,716 | $-1 | $N/A | $1,194 |
| Beginning Cash Position | 4,455 | 4,455 | 4,455 | 4,455 | 15,962 |
| End Cash Position | 148,989 | 161,375 | 11,675 | 15,018 | 4,455 |
| Net Cash Flow | $144,534 | $156,920 | $7,220 | $10,563 | $-11,507 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,423 | -9,995 | 7,378 | 10,563 | -12,701 |
| Capital Expenditure | -46 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -22,469 | -9,995 | 7,378 | 10,563 | -12,701 |